Delivery Order SPE2DB22D3016-SPE2DB25FBKM1
Award Date 9/22/25
Potential Completion Date 9/23/25
Potential Value $60K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 15, 2025, for Prolia 60 mg/mL syringes valued at $12,957.22. The contract employs firm fixed pricing with an ultimate completion date of September 16, 2025, and was competitively awarded without set-aside designation. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,723.10 by the Defense Logistics Agency on August 5, 2025, for the supply of Prolia 60 mg/ml syringes. The contract utilizes firm fixed price terms and carries an ultimate completion date of August 6, 2025. This award is unset-aside and was competitively awarded through the federal procurement process. The delivery order will be fulfilled from the vendor's Corporate Office...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,601.60 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Prolia 60 mg/ml syringes. The contract is not set-aside and operates under a firm fixed-price delivery order model, with performance to be completed by July 15, 2025, at the vendor's Conshohocken, Pennsylvania facility. This award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for PROLIA 60 mg/mL syringes valued at $13,150.17 by the Defense Logistics Agency on September 16, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a non-competitive award issued under an existing contract vehicle. The award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and fulfills...
- The Defense Logistics Agency (DLA) awarded a Delivery Order valued at $14,887.74 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Prolia 60 mg/ml syringes. This non-set-aside, firm fixed price contract is scheduled for completion by August 20, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $14,539.96 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of September 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office located in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,714.50 to AmerisourceBergen Drug Corp for PROLIA 60 mg/ml syringes, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical prime vendor agreement with DLA Troop Support. The product will be delivered to the contractor's location in...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on August 26, 2025, for the supply of Prolia 60 mg/ml syringes with a ceiling value of $12,857.40. This competitive, non-set-aside award is structured as a firm fixed price delivery order with a completion date of August 27, 2025. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, a comprehensive...
- The Defense Logistics Agency awarded a $26,034.19 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes under a firm fixed-price contract. The delivery order, issued on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a competitively awarded non-set-aside procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $35,094.09 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/mL syringes on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order represents a competitively awarded non-set-aside contract executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The...